August 14, 2026 Financial Results Briefing Material for the First Quarter of the Fiscal Year Ending March 2027 Kusurinomadoguchi, Inc. ©kusurinomadoguchi, inc. All Right Reserved. Securities Code: 5592 Table of Contents Overview of Q1 FY03/202 7…
August 14, 2026
Financial Results Briefing Material for the
First Quarter of the Fiscal Year Ending
March 2027
Kusurinomadoguchi, Inc.
©kusurinomadoguchi, inc. All Right Reserved.
Securities Code: 5592
Table of Contents
- Overview of Q1 FY03/202 7
- Performance Report for
Q1 FY03/2027
-
Business Description and Performance
Healthcare Automation Business
Everyone’s Medicine Box Business
Core Systems Business
Wellness Platform Business
-
Earnings Forecast for FY03/2027
-
Medium- Term Management Plan
©kusurinomadoguchi, inc. All Right Reserved.
2
Overview of Consolidated Financial Results for Q1
FY03/2027
©kusurinomadoguchi, inc. All Right Reserved.
- Q1 FY3/2027 Consolidated Financial Results
About Business Name Change
Purpose of Business Name Change
To build and strengthen a service framework spanning medical institutions and pharmacies,
and aim for expansion of business domains.
「Media Business 」 renamed to
「Pre - Disease Prevention Business 」 renamed to
Future Disclosure Policy
Healthcare Automation Business
Wellness Platform Business
Drive AI adoption to address the social challenge of labor
shortages and achieve healthcare DX
Through an AI - powered wellness platform, achieve operational
efficiency for insurers and health promotion for members
Amid declining birthrates, an aging population, and a shrinking workforce, the
healthcare sector is facing a deepening, chronic labor shortage.
By analyzing members' health and behavioral data, we deliver personalized
To address this societal challenge, we are deploying an AI
- powered business
automation platform for the healthcare sector
—one that provides end - to- end
automation spanning patient acquisition, appointment scheduling, reception,
medical questionnaires, billing, and administrative tasks. Our solution unifies
and automates the entire patient journey, which has traditionally been
fragmented across siloed processes.
health services. Continuously connecting insurers with members, we
By driving the adoption of AI across the healthcare sector and building a new
cross - cutting operational infrastructure that spans hospitals, clinics, and
pharmacies, we aim to solve the societal challenge of labor shortages while
realizing digital transformation (DX) in healthcare.
health information, visit recommendations, follow
contribute to advancement of health initiatives, healthcare cost optimization,
⚫ Ongoing performance disclosure
under new standards
⚫ Unification and consistency of KPI definitions
⚫ Continue transparent disclosure to investors
and value creation.
With AI at the core, we connect people, insurers, services, and data to drive
DX across the healthcare domain
Accounting Impact
— working toward a sustainable healthcare
⚫ No change in the revenue recognition method
society.
⚫ No impact on the cash flow structure
⚫ No fundamental changes in the main KPIs
As a healthcare platform company,
we aim for further growth
©kusurinomadoguchi, inc. All Right Reserved.
~FY3/2026
Pre - Disease Prevention Business
| Medical Check - up
~FY3/2026
FY3/2027 ~
Healthcare Automation Business
| Medical Check-up
⚫ Past performance has been restated under
the new standards
4
- Q1 FY3/2027 Consolidated Financial Results
About the MHLW Notice
Overview
Q3 Was it confirmed with MHLW that there are no issues with our business operations?
Key questions from investors
A.
and our responses
We explained that the survey questionnaires and point programs related to
prescription reservation that were the subject of discussion have already
been terminated, and confirmed that no particular issues or concerns were
raised . We also notified all regional health bureaus of the same .
Q3 Are there any issues with the point programs still ongoing?
The MHLW notice dated June 23, 2026
"Regarding the prohibition of solicitation through economic benefit under the Health Insurance
A.
Pharmacy Practice Regulations"
contained a description that cannot be denied as related to our business.
As we have received investor questions regarding this matter,
we are republishing our responses.
The only ongoing point program is for medication record entry and check - in.
This does not direct patients to specific pharmacies — it is awarded at all
pharmacies including those not affiliated with us — and we believe it does not
conflict with the MHLW notice .
Q4 Can the prescription reservation service continue?
A.
As stated in our MHLW explanation referenced in A2, and in all prior
interactions, the prescription reservation service itself has never been cited
as patient solicitation . We therefore plan to continue this service going
forward .
Q1 Does the MHLW notice identify our survey programs and point grants as problematic?
Q5 Is there any impact on business performance from the MHLW notice?
A. In November 2025, the Central Social Insurance Medical Council raised
A.
potential patient solicitation as a discussion point. Following internal review,
we concluded the programs aimed at quality improvement rather than
solicitation and were legally permissible . However, to avoid any
inconvenience
to pharmacies
and users, we phased out survey
questionnaires and point programs related to prescription reservation
services, completing the phase - out by May 2026.
©kusurinomadoguchi, inc. All Right Reserved.
As noted in A4, we will continue the prescription reservation service, while as
noted in A1, we have discontinued the survey questionnaires and point
programs that could be considered problematic . We therefore see no
impediment to our operations and expect minimal impact on performance . No
significant changes have occurred in online prescription volume, pharmacy
contract count, or cancellation rate, and we will respond promptly to any
concerns raised by MHLW or other authorities .
5
- Q1 FY3/2027 Consolidated Financial Results
About Treasury Stock Buyback
Purpose of Treasury Stock Acquisition
To improve capital efficiency and enhance
returns to our shareholders, as well as to
enable agile capital policy in response to
changes in the business environment, we
are conducting share buybacks.
We are repurchasing treasury stock to improve capital efficiency, enhance returns to
shareholders, and implement flexible capital policies in response to changing business
conditions. At the Board of Directors meeting held on June 5, 2026, an initial program of 115,000
shares and ¥300 million was authorized; subsequently at the Board of Directors meeting on June
29, 2026, the program was expanded to 400,000 shares and ¥800 million.
Going forward, we will continue to pursue capital policies that enhance corporate value, taking
comprehensive account of capital efficiency, financial soundness, and market conditions.
©kusurinomadoguchi, inc. All Right Reserved.
Overview of Acquisition Program
(1) Type of shares to be
acquired
Common shares of the Company
(2) Total shares to be
acquired
400,000 shares (max); 3.51% of issued shares excl.
treasury
(3) Total acquisition cost
¥800,000,000 (maximum)
(4) Acquisition period
June 8, 2026 – December 7, 2026 (trade date basis)
(5) Acquisition method
Market purchases on TSE pursuant to a discretionary
trading agreement
Acquisition Status
(1) Type of shares
acquired
(2) Total number of
shares acquired
Company common shares
216,400 shares
(3) Total acquisition cost
¥524,611,400
(4) Acquisition period
June 8 to July 31, 2026 (trade date basis)
(5) Acquisition method
Market purchase on the Tokyo Stock Exchange under a
discretionary trading agreement
6
- Q1 FY3/2027 Consolidated Financial Results
Q1 FY3/2027 Consolidated Financial Results
FY3/2027 Q1
Consolidated net sales for the quarter increased, along with
profit growth, as a result of steady accumulation in revenue
from the Healthcare Automation business and the Core
Systems business, as well as in Recurring gross profit.
Consolidated
Revenue
3.64
Everyone’s Medicine
Box Business
Core Systems
Business
Due to a temporary operational delay associated with the warehouse
relocation for the Slow - moving Inventory Service, a portion of sales
originally expected in the fourth quarter of the fiscal year ended March 2025
shifted into the first quarter of the fiscal year ending March 2026, resulting
in a slight decrease in Recurring gross profit for that quarter. Excluding this
impact, both sales and profit increased year
©kusurinomadoguchi, inc. All Right Reserved.
billion
yen
+24.6%
YoY
1.62
billion
yen
YoY
+37.3%
0.94
YoY
billion
yen
billion
yen
YoY
+26.4%
billion
yen
0.62
YoY
+57.3%
0.35
YoY
billion
yen
△8.0%
Recurring
Gross Profit
Revenue
YoY
1.06
Recurring
Gross Profit
+7.8%
1.03
Recurring
Gross Profit
Recurring
Gross Profit
Revenue
Revenue
Owing to the consolidation effect from Techno Network Co., Ltd. and
temporary special demand arising from a change in laws and
regulations, both sales and profit increased compared to the same
period of the previous year.
*As we operate as a single reporting segment, segment revenue and Recurring gross profit are used as key performance indicato
0.78
billion
yen
+25.0%
YoY
In addition to the consolidation effect from Medi Web Co., Ltd., steady
growth in the number of online prescription reception counts and the
number of facilities held drove year - on- year increases in both sales
and profit.
Healthcare
Automation
Business
Consolidated
Operating Profit
billion
yen
+25.9%
0.18
YoY
billion
yen
+31.2%
rs.
7
- Performance Report for Q1 FY03/2027
©kusurinomadoguchi, inc. All Right Reserved.
- Performance Report for Q1 FY03/2027
Consolidated Revenue
Consolidated Revenue grew significantly by 25% year
- on- year, driven by consolidation effects from M&A and
special demand from regulatory changes.
Recurring Revenue has also been steadily accumulating, reaching a new record
- high level.
Recurring Revenue (Millions of Yen)
YoY +25.0%
Non- recurring revenue (million yen)
3,643
3,402
3,102
2,976
2,813
2,778
2,914 2,910
1,103
943
2,629
966
2,462
2,153
1,623
1,347
924
693
958
551
656
1,380
672
662
673
758
777
748
664
649
1,855
673
1,990
684
371
717
334
372
384
443
656
314
567
811
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
FY3/2021
©kusurinomadoguchi, inc. All Right Reserved.
865
965
975
1,078
2Q
3Q
4Q
1Q
FY3/2022
815
697
2,004
776
869
1,112
853
928
542
2,459
711
378
FY3/2020
1,639
1,748
1,484
1,154
780
706
1,328
1,742
1,826
1,116
2,101
919
1,099
1,184
1,303
2Q
3Q
4Q
FY3/2023
1,337
1Q
1,404
1,461
2Q
3Q
FY3/2024
1,685
1,760
4Q
1Q
1,701
2Q
1,860
1,925
1,995
3Q
4Q
1Q
FY3/2025
1,982
2Q
2,540
2,135
3Q
FY3/2026
4Q
1Q
FY3/2027
9
- Performance Report for Q1 FY03/2027
Consolidated Recurring Gross Profit
In Q1 FY3/2027, Recurring gross profit reached a new record high, driven by growth in Recurring Revenue
from both Healthcare Automation Business and Core Systems Business.
YoY +26.4%
1,069
Consolidated Recurring Gross Profit (million yen)
1,069
1040
888
846
753
662
690
799
780
653
534
396
431
467
307
1Q
2Q
FY3/2020
4Q
1Q
2Q
3Q
135
114
1Q
2Q
208
195
3Q
4Q
252
263
1Q
2Q
4Q
FY3/2021
©kusurinomadoguchi, inc. All Right Reserved.
FY3/2022
3Q
FY3/2023
4Q
1Q
2Q
3Q
FY3/2024
4Q
1Q
2Q
3Q
FY3/2025
4Q
1Q
2Q
3Q
FY3/2026
4Q
1Q
FY3/2027
10
- Performance Report for Q1 FY03/2027
Consolidated Operating Profit
Consolidated operating profit reached a new record high, driven by revenue growth of more than 20% in
both Healthcare Automation Business and Core Systems Business.
YoY +24.6%
784
Operating Profit (million yen)
753
606
666
629
632
1Q
2Q
567
458
384
397
382
330
275
228
199
223
219
240
217
2Q
3Q
258
268
3Q
4Q
173
107
82
70
227
3Q
FY3/2020
4Q
1Q
2Q
3Q
4Q
FY3/2021
©kusurinomadoguchi, inc. All Right Reserved.
1Q
2Q
3Q
FY3/2022
4Q
1Q
FY3/2023
4Q
1Q
2Q
FY3/2024
1Q
2Q
3Q
FY3/2025
4Q
3Q
FY3/2026
4Q
1Q
FY3/2027
11
- Performance Report for Q1 FY03/2027
Consolidated SG&A and Headcount
SG&A expenses and headcount have increased due to the expansion of business scale and staffing growth
accompanying subsidiary consolidation.We will continue to actively promote AI utilization, aiming to improve
operational efficiency and productivity, thereby reducing SG&A and strengthening the earnings base.
SG&A (million yen)
Headcount (persons)
Number of Employees
1,314
SES
756
737 726
1,220
1,159
1,096
1,124
1,162
686
1,075 1,059
986
1,022
547
513 518
867
744
658
620
682
786 795 796 803
702
742
424
361
568 573
541
288
440
67
221
1Q
2Q
3Q
FY3/2021
4Q
1Q
2Q
3Q
FY3/2022
4Q
1Q
2Q
3Q
FY3/2023
4Q
1Q
2Q
3Q
FY3/2024
©kusurinomadoguchi, inc. All Right Reserved.
4Q
1Q
2Q
3Q
FY3/2025
4Q
1Q
2Q
3Q
4Q
FY3/2026
FY3/2027
1Q
1Q
307
53
377
93
444
99
469
110 104
117
579 571 578
600
124 130 128 155
712
671 675
151 143
565 156
680
648 651
161
149 142
132
119
133 122
147
106
60
586 583
54
530
308
345 363
317 331
3Q
4Q
624
551
522 533 515 529
3Q
4Q
561
430 455 441 450 445 418
403 414
253
2Q
FY3/2021
1Q
2Q
3Q
FY3/2022
4Q
1Q
2Q
3Q
FY3/2023
4Q
1Q
2Q
3Q
FY3/2024
4Q
1Q
2Q
FY3/2025
*The employee count of Medi - Web was not reflected in the FY3/2026 annual results document;
it has been retroactively added.
1Q
2Q
3Q
4Q
1Q
FY3/2026
FY3/2027
12
- Performance Report for Q1 FY03/2027
Consolidated Income Statement
Revenue and each stage of profit increased year
- on- year. Meanwhile, net income attributable to
parent company shareholders decreased quarter
- on- quarter, primarily due to the reversal of a
one- time profit boost from deferred tax effects in the prior quarter.
Unit: million yen
FY3/2027
Q1
FY3/2026
Q1
Growth Rate (%)
FY3/2026
Q4
Growth Rate (%)
Revenue
3,643
2,914
+25.0 %
3,402
+7.1%
Gross Profit
2,099
1,688
+24.3 %
1,886
+11.3%
Operating Profit
784
629
+24.6 %
666
+17.7%
Ordinary Profit
778
645
+20.6%
654
+18.8%
Net income attributable to
owners of the parent
623
386
+61.0%
839
△25.8 %
EBITDA
1,194
979
+22.0%
1,066
+12.1%
©kusurinomadoguchi, inc. All Right Reserved.
13
- Performance Report for Q1 FY03/2027
Performance Progress Rate for Q1 FY03/2027
FY3/2027
Q1 Actual
Revenue
Earnings forecast
For FY03/2027
Progress rate
3,643 million yen
Operating
14,400million yen
25 %
Progress rate
784 million yen
profit
Ordinary
25 %
3,100million yen
Progress rate
778 million yen
Profit
0%
10%
©kusurinomadoguchi, inc. All Right Reserved.
20%
3,100million yen
25 %
30%
40%
50%
60%
70%
80%
90%
100%
14
- Performance Report for Q1 FY03/2027
Consolidated Balance Sheet
The increases in cash and deposits and liabilities are attributable to short
borrowings for working capital purposes by the Group.
FY3/2027
Q1
FY3/2026
Q1
Growth Rate (%)
FY3/2026
Q4
18,227
11,874
+53.5 %
17,816
+2.3%
9,931
5,879
+68.9 %
10,090
△1.6%
4,509
1,888
+138.8%
5,203
△13.4%
8,296
5,995
+38.4 %
7,726
+7.4%
6,771
3,249
+108.4%
6,352
+6.6%
Current liabilities
5,564
2,772
+100.7%
5,203
+6.9%
Non- current liabilities
1,207
477
+153.0%
1,148
+5.1%
11,456
8,625
+32.8%
11,464
△0.1%
Unit: million yen
Total assets
Current assets
Cash and Cash Equivalents
Non- current assets
Total Liabilities
Equity
©kusurinomadoguchi, inc. All Right Reserved.
Growth Rate (%)
15
- Performance Report for Q1 FY03/2027
EBITDA
EBITDA is progressing steadily, supported by the solid expansion of our revenue base.
Underpinning this growth are not only the strengthening of existing businesses, but also our ongoing investment in software
and the steady execution of strategic M&A.
FY3/2023
FY3/2024
FY3/2025
FY3/2026
FY3/2027
Q1
Revenue
7,420
8,721
11,199
12,330
3,643
EBITDA
1,883
2,312
3,262
4,186
1,194
1,050
1,370
1,953
2,681
784
Depreciation expense
788
978
1,221
1,414
375
Amortization of Goodwill
45
54
86
90
35
Operating Margin
14.1%
15.7%
17.4%
21.8%
21.5%
EBITDA margin
25.4 %
26.5%
29.1%
34.0 %
32.8 %
Operating Profit
※EBITDA =Operating profit +Depreciation Expense +Amortization of Goodwill
©kusurinomadoguchi, inc. All Right Reserved.
16
- Business Description and Performance
Healthcare Automation Business
©kusurinomadoguchi, inc. All Right Reserved.
- Business Description and Performance
Healthcare Automation Business
Japan's largest pharmacy
reservation platform,
offering reservation services
spanning clinics and
hospitals across the medical
and healthcare sector
Surpassed 7 million
downloads
EPARK Kusurinomadoguchi
EPARK Medication
Notebook App
EPARK complete
medical checkup
EPARK Clinic/Hospital
Rich Plan
EPARK
Kusurinomadoguchi
Premium Listing Plan
Revenue: Healthcare Automation Business
System usage fee from online
prescription acceptance
Initial installation cost
(registration, setup fees, etc.
Pharmacy
Self - operation
Products
Non- recurring Revenue
Recurring Revenue
)
Number of reservations
2,988
4,168
Monthly usage fee from premium
listing plan adoption and user
retention promotion
©kusurinomadoguchi, inc. All Right Reserved.
Rich Plan
Pharmacy Support
Initial installation cost
(installation, registration,
setup fees, etc.)
5,068
6,036
7,264
5,128
1,250
2,027
Hospitals &
Clinics
(thousand)
4,478
2,661
Monthly usage fee from AI
Receptionists,
Unmanned Checkout Machines, etc.
(Millions of Yen)
(Millions of Yen)
Initial installation cost
(unit price, installation fee, etc.)
Self - operation
Products
Rich Plan
Pharmacy Support
Unmanned Checkout
Machine
CRM system specialized
in patient retention
Non- recurring revenue
Commission for courses visited
by users and facility listing fee
revenue
AI Receptionist
Cumulative DL
Leading medication
notebook app
Recurring Revenue
EPARK complete
medical checkup
EPARK Clinic/Hospital
|Business Model
625
3,063
1,664
FY3/2022
FY3/2023
Q1
Actual
603
363
2,035
1,421
2,460
1,626
3,057
3,877
381
1,245
FY3/2024
FY3/2025
FY3/2026
Recurring Revenue: Revenue expected on a continuing basis under monthly contracts.
Non - recurring revenue: One - time revenue such as initial setup fees.
FY3/2027
18
- Business Description and Performance
|Revenue
Healthcare Automation Business
Recurring Revenue grew year
Medi- Web.
- on- year, driven by growth in online prescription acceptance and the consolidation of
*Medical check - up revenue has been retrospectively reclassified to Healthcare Automation Business going forward.
YoY +37.3%
Recurring Revenue (Millions of Yen)
Non- recurring revenue (million yen)
1,577
307
1,181
1,114
1,094 1,087
1,626
381
1,185 1,155 1,211
276
890
738
589
561
457
311
197
459
438
166
143
475
177
435
426
119
82
451
381
67
482
87
505
69
139
616
139
648
660
187
155
145
436
450
516
395
492
366
383
477
344
4Q
1Q
2Q
3Q
FY3/2022
4Q
1Q
2Q
3Q
FY3/2023
4Q
260
292
295
299
316
1Q
2Q
3Q
FY3/2020
4Q
1Q
2Q
3Q
FY3/2021
147
15
551
249
701
©kusurinomadoguchi, inc. All Right Reserved.
724
132
746
367
363
284
351
315
405
212
111
1,269 1,245
830
833
839
4Q
1Q
2Q
3Q
FY3/2026
635
678
731
682
4Q
1Q
2Q
3Q
FY3/2025
554
592
1Q
2Q
3Q
FY3/2024
934
814
4Q
1Q
FY3/2027
19
- Business Description and Performance
|Recurring Gross Profit
Healthcare Automation Business
Recurring gross profit was slightly down quarter
-
on- quarter, reflecting a reversal of the one
prior quarter.
The underlying business remains on a solid trajectory.
-
time seasonal uplift in the
*Recurring gross profit has been retrospectively reclassified to Healthcare Automation Business going forward.
YoY +57.3%
636
627
4Q
1Q
FY3/2027
Recurring Gross Profit (Millions of Yen)
427
398
355
350
2Q
3Q
FY3/2025
4Q
364
285
122
65
146
175
197
240
220
89
20
1Q
2Q
3Q
FY3/2020
4Q
1Q
2Q
3Q
FY3/2021
4Q
©kusurinomadoguchi, inc. All Right Reserved.
1Q
2Q
3Q
FY3/2022
4Q
1Q
2Q
3Q
FY3/2023
4Q
1Q
2Q
3Q
FY3/2024
4Q
1Q
1Q
2Q
3Q
FY3/2026
20
- Business Description and Performance
|KPI (Key Performance Indicators)
Healthcare Automation Business
Cross - selling from EPARK Kusurinomadoguchi into the Medication Notebook App is progressing steadily, strengthening our
business foundation.
The number of facilities is also on a solid growth trajectory.
450
Our online
Number of reservations (thousand)
Number of Contracted Facilities
Medication notebook DL (thousand)
7,667
7,051 7,377
6,165
4,906
2,105
683
2,277
698
2,454
822
2,689
820
2,902
946
3,141
985
3,372
3,634
3,873
4,119
Number of
prescriptions *1
5,224
5,499
6,439
Approx . 9.0
6,718
million pages
5,812
Million
pages
prescription
accept. target
(SAM)
370 million
Pediatric prescriptions*3
4,407
80 million
+400 thousand
YoY
1,319 1,339 1,387 1,426
1,080 1,159 1,204 1,205
1,636 1,587 1,613 1,713
1,929 2,009 2,012
YoY +1,605
facilities
17,569 17,920 17,869 18,121 18,278 18,535 18,807
19,293 19,605
2Q
3Q
4Q
1Q
FY3/2022
2Q
3Q
FY3/2023
4Q
1Q
2Q
3Q
FY3/2024
4Q
1Q
2Q
3Q
FY3/2025
4Q
1Q
2Q
3Q
4Q
©kusurinomadoguchi, inc. All Right Reserved.
16.8facilities
Not disclosed
FY3/2026
– Mar 2024)
*2. Calculated at 1.2 prescriptions per reservation
Madoguchi Q has been discontinued
considering its materiality and usefulness.
Approx.
Our share
1Q
*1. Total dispensing medical costs, number of prescriptions (Apr 2023
*Disclosure of average UU for
Self - operation
market locations *6
Our share
Approx. 39.3%
1Q
official data published by MHLW or the Statistics Bureau.
Not disclosed
*4
million people
*These figures are our own estimates and do not represent
Approx. 2.0%*2
facilities
24,694
24,694
23,089
23,089
72.66
Our share
Number of pharmacies
23,953 24,312 24,539
Approx.
Our share
Approx. 63,000
22,008 22,285 22,368
20,243 20,584 21,033 21,532
Health check - up visitors *5
Long - term
prescription ratio*3
FY3/2027
*3. Based on *1, prescription ratio derived from claims data of dispensing
pharmacies, then applied to annual nationwide prescription volume to estimate market size
*4. MHLW "Overview of Sanitary Administration Report (Mar 2023 preliminary)"
*5. MHLW "Comprehensive Survey of Living Conditions (2022)" (checkup rate)
/ "FY2023 Specific Health Check - up Implementation Status" (reference data)
/ Statistics Bureau "Population Estimates“
(as of Oct 1, 2022, used for 20+ population)
*6. *4 + MHLW "Medical Facilities Survey
(Dec 2025 preliminary) — General clinic count"
21
- Business Description and Performance
Healthcare Automation Business
Unmanned
Checkout Machine
Reducing staff operational burden while also automating promotional
activities.
We will further advance our expansion into the medical field,
aiming to serve a wider range of clinical sites.
Home Delivery
Medication can be received
by specifying delivery address
Locker Pickup
Medication can be received
from designated locker
System Integrations
w/ Receipt Computer
Systems
We deliver integrated services from patient arrival through billing and
medication handover.
|Topics
AI
AI
・Streamline billing operations
・Cash and cashless payment support
Integration
In - store AI
Reception
・Paper medicine
・Prescription reception
notebook collection
・Reception ticket issuance
・Dispensing complete
Prescription
AI OCR
・Automatic prescription reading
・Dispensing system integration
AI
w/ Receipt Computer
Systems
Integration
Receipt Computer
Systems
・Automatic prescription entry
・Claims data entry delegation
・Head office data entry
Medication record /
AI voice medication
record
・Auto- transcription of co - medications
・Auto- transcription of follow- up notes
Ordering
System
・Automatic ordering system
・Group inventory sharing
・Prescription
・My Number
・Medication notebook data
・Ticket issuance data
Revenue growth initiatives
Smartphone
Check - in
Pre- send photographed prescription
to reduce pharmacy wait time
©kusurinomadoguchi, inc. All Right Reserved.
DMP
Automatically analyze and notify the
information that should be shared with patients
Auto Entry
Automatically reflects medication, billing,
and health check info — no manual entry
Medication
Follow - up
Auto- identifies patients for follow- up
and delivers follow- up messages
AI AI Stock
(Inventory)
Displays pharmacies with inventory and
dispensing historybased on dispensing records,
and drives patient traffic
22
- Business Description and Performance
Everyone's Medicine Box Business
©kusurinomadoguchi, inc. All Right Reserved.
- Business Description and Performance
Everyone's Medicine Box Business
J - Seed Co., Ltd.
Providing optimal
procurement support
services through Japan's
largest scale distribution
improvements
Recurring Revenue
AI- powered automatic
inventory ordering
system
Non- recurring revenue
|Business Model
B2B
marketpla
ce of
inactive
medication
inventory
One of Japan’s largest
pharmaceutical
buying/selling matching
sites.
Non- recurring Revenue
Commission calculated based
on drug purchase amount
Recurring Revenue
(Inventory management)
Monthly usage fee for
automatic inventory
management
(Millions of Yen)
(Millions of Yen)
Distribution volume (Millions of Yen)
233,084
200,576
158,104
224,535
232,103
3,547
3,503
Pharmacies
e- Order
(Inventory management)
2,987
557
1,090
(setup, registration fees, etc.)
1,600
Q1
Actual
2,413
1,387
462
1,175
Hospitals &
Clinics
Everyone’s Medicine
Box Electricity
3,127
3,009
Initial installation cost
B2B marketplace of
inactive
medicationinventory
Fees based on the
transaction of pharmaceuticals
actually conducted
Everyone’s
Medicine
Box Electricity
Revenue: Everyone's Medicine Box Business
Procurement Support
e- Order
Provide an optimal power
supply environment for
dispensing pharmacies
and medical institutions.
2,990
2,664
1,833
940
176
763
Monthly electricity usage fee
FY3/2022
FY3/2023
FY3/2024
FY3/2025
FY3/2026
Recurring sales: Defined as sales that are expected to be obtained on a continuous basis, to a certain extent, based on contr
FY3/2027
act s such as monthly usage fees.
Non - recurring revenue: Defined as sales obtained temporarily, such as initial setup costs.
©kusurinomadoguchi, inc. All Right Reserved.
GMV (gross merchandise value): The sum of the pharmaceutical prices matched by the inactive medication inventory service and
of pharmaceuticals purchased through the purchasing support service.
the amount
24
- Business Description and Performance
|Revenue
Everyone's Medicine Box Business
Revenue increased year - on- year. Recurring Revenue was slightly down, mainly due to a temporary operational delay from
the Slow - moving Inventory Service warehouse relocation, which caused part of revenue originally scheduled for Q4
FY3/2025 to shift into Q1 FY3/2026. Excluding this effect, both Revenue and profit would have increased year
- on- year.
Recurring Revenue (Millions of Yen)
Non- recurring revenue (million yen)
YoY +7.8%
925
955
830
738
734
752
645
830
773
772
679
444
432
586
472
738
632
567
490
452
941
351 320
439
761 737
374
368
209
872
821 803
792 778
137
723
117
296 208
109
165
61
48
55
58
65
1Q
2Q
3Q
4Q
FY3/2020
116 152
1Q
2Q
207 244
3Q
4Q
FY3/2021
©kusurinomadoguchi, inc. All Right Reserved.
176
117
265
502
374
99
201 135
940
82
528
220
162
102
836
896
300
386 368 422
333
1Q
2Q
3Q
FY3/2022
4Q
1Q
418 465
2Q
3Q
FY3/2023
529 550
4Q
1Q
587
621 654
660 640
2Q
3Q
1Q
FY3/2024
4Q
2Q
659 704
3Q
FY3/2025
4Q
769
719 740
761 763
1Q
2Q
4Q
3Q
FY3/2026
1Q
FY3/
2027
25
- Business Description and Performance
|Recurring Gross Profit
Everyone's Medicine Box Business
A temporary operational delay from the Slow - moving Inventory Service warehouse relocation caused part of Q4 FY3/2025
revenue to shift into Q1 FY3/2026, resulting in lower Recurring gross profit for the quarter. Excluding this effect, both
Revenue and profit exceeded the prior - year period.
Recurring Gross Profit (Millions of Yen)
YoY △8.0%
382
348
327
185
154
132 142
61
19
20
1Q
2Q
265
4Q
1Q
383
387
351
345
334
323
300
280
197
165
75
30
9
11
9
3Q
4Q
1Q
FY3/2020
183
258
368
2Q
3Q
4Q
FY3/2021
©kusurinomadoguchi, inc. All Right Reserved.
1Q
2Q
3Q
FY3/2022
4Q
1Q
2Q
3Q
FY3/2023
2Q
3Q
FY3/2024
4Q
1Q
2Q
3Q
FY3/2025
4Q
1Q
2Q
3Q
FY3/2026
4Q
1Q
FY3/
2027
26
- Business Description and Performance
Everyone's Medicine Box Business
|KPI (Key Performance Indicators)
※Procurement Support + Slow
Number of facilities
Distribution volume (Procurement Support + Slow
- moving Inventory) (million yen)
Pharmaceutical GMV
YoY +6,254
Million
61,571
57,816
58,990 58,514
54,707
54,362
56,676 57,702
Approx.
57,430
51,644
51,100
46,948
55,763 56,695
11.8trillion yen
*3
62,017
60,688
Pharmacy
*1
Approx. 4.0
trillion yen
+
48,167
*2
43,439 42,917
37,534
Our share
Approx.
34,214
Approx.
27,909
YoY +1,533
23,349
Hospitals & Clinics
facilities
Approx. 7.8
trillion yen
2.0%
15,840
8,565
Target facilities
Approx.
8,589
7,130 7,717 8,121
10,479
9,206 9,860
10,992 11,593
12,352
12,961 13,627
15,543
14,232 14,835
16,010 16,953
17,522 17,901
18,224 18,645
18,019
19,375
19,375
180,000
19,552
17,901
Our share
facilities
Approx.
FY3/2021
FY3/2022
FY3/2023
FY3/2024
FY3/2025
FY3/2026
+
*2
113,585facilities
Approx.
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q
62,828 facilities
Medical Institutions
0.5
%
11.1
%
4,725
Pharmacy *1
*1. MHLW "Overview of Sanitary Administration Report (Mar 2023 preliminary)"
FY3/2027
©kusurinomadoguchi, inc. All Right Reserved.
*2. MHLW "Medical Facilities Survey (Dec 2025 preliminary)"
*3. IQVIA drug market statistics
— sales data (Apr 2025
– Mar 2026)
27
- Business Description and Performance
Everyone's Medicine Box Business
Inter - store Sharing Feature Release
Optimizing inventory across
pharmacy chain stores
A system that optimizes inventory
across stores by facilitating
medication transfers between
locations based on pre - configured
inventory levels and dispensing
demand forecasts.
Expansion of the B2B Marketplace of
Inactive Medication Inventory
By leveraging cost savings from
digitizing warehouse management at
our subsidiary PeakWell , we
implemented price reduction
measures including high - value
purchases of inactive inventory from
member pharmacies, successfully
acquiring large and mid - sized
companies.
|Topics
Inter - regional sharing feature inquiry
Optimize inventory across
local pharmacy locations
OTC Product Handling
We cover all 48 therapeutic
categories with over 500 products
available, including the complete
5coins series lineup.
A system that optimizes inventory
across regional stores by
facilitating medication transfers
between locations based on each
store's stock levels.
1,000
Expected Benefits
• Reduced pharmaceutical waste
• Lower procurement costs
• Optimized inventory management
We will expand our B2B
marketplace of inactive medication
inventory customer base by
implementing AI technology in our
warehouse management to achieve
further cost savings and pass them
on to customers.
©kusurinomadoguchi, inc. All Right Reserved.
Increased inquiries
28
- Business Description and Performance
Core Systems Business
©kusurinomadoguchi, inc. All Right Reserved.
- Business Description and Performance
Core Systems Business
| Business Model
Nursing Care
Hospitals & Clinics
Pharmacy
Provide receipt computer,
medication history data and
dispensing accuracy check
systems for pharmacies.
ORCA
Recurring Revenue
Non- recurring revenue
Pharmy /Hi_story
/Cube.i
Pharmy /Hi_story
/Cube.i
Monthly usage fee for
receipt computer system,
medication
records,and audit system
Pharmacy
HOSPITAC/
Ex_Karte (EHR)/
ORCA
Monthly usage fee for patient
information management
systems
Initial installation cost
(installation, setup fees, etc.)
Comet Care
Comet Care
(Electronic records for
nursing care facilities)
(Electronic records for
nursing care facilities)
Monthly fees for providing
information management
for facility users (residents)
systems
Nursing Care
Revenue: Core Systems Business
Non- recurring Revenue
Recurring Revenue
(Millions of Yen)
(Millions of Yen)
Initial installation cost
(installation, setup fees, etc.)
2,150
3,529
3,484
2,040
1,878
1,749
Q1
Actual
1,475
1,139
1,038
953
908
1,489
567
FY3/2022
©kusurinomadoguchi, inc. All Right Reserved.
Providing billing system,
records system,
and monitoring devices
Initial setup costs
(Installation and
configuration fees, etc.)
HOSPITAC/
Ex_Karte (EHR)/
ORCA
Hospitals &
Clinics
Medical billing/ordering
integrated EHR / EHR /
outpatient support
system
796
FY3/2023
1,607
526
1,011
512
FY3/2024
FY3/2025
FY3/2026
Recurring Revenue: Revenue expected on a continuing basis under monthly contracts.
Non - recurring revenue: One - time revenue such as initial setup fees.
FY3/2027
30
- Business Description and Performance
|Revenue
Core Systems Business
Revenue grew significantly by 25.9% year - on- year, driven by the consolidation of Techno Network (joined May
2026) as well as temporary special demand in Non
- recurring revenue arising from regulatory changes.
YoY +25.9%
Recurring Revenue (Millions of Yen)
1,038
Non- recurring revenue (million yen)
996
966
850
780
882
824
454
361
223
174
265
260
223
434
362
297 259
174
422
526
293
180
188 202
223
232 225 205
2Q
3Q
4Q
1Q
2Q
4Q
1Q
6
29
99
105
108
128
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
FY3/2021
©kusurinomadoguchi, inc. All Right Reserved.
FY3/2022
378
512
158
36
11
25
469 485
197 222
231
143
34
11
23
490
294
138
29
10
20
461 433
427
132
24
7
17
FY3/2020
257
438
118 157
35
75
400
426
901
741
618 582
516 526
876
3Q
FY3/2023
2Q
3Q
FY3/2024
354
363
377 384
388
390
392 407
4Q
1Q
2Q
4Q
1Q
2Q
3Q
FY3/2025
3Q
FY3/2026
417
4Q
1Q
FY3/
2027
31
- Business Description and Performance
|Recurring Gross Profit
Core Systems Business
Recurring gross profit reached a new record high, driven by the consolidation of Techno Network.
Even excluding the consolidation effect, performance has remained on a steady trajectory.
Recurring Gross Profit (Millions of Yen)
YoY +31.2%
182
154
57
63
65
1Q
2Q
74
69
69
1Q
2Q
59
64
68
76
69
148
153
139
147
139
117
112 115
2Q
3Q
75
47
17
19
17
1Q
2Q
3Q
FY3/2020
26
24
4Q
1Q
18
2Q
3Q
4Q
FY3/2021
©kusurinomadoguchi, inc. All Right Reserved.
3Q
FY3/2022
4Q
3Q
FY3/2023
4Q
1Q
2Q
3Q
FY3/2024
4Q
1Q
2Q
3Q
FY3/2025
4Q
1Q
FY3/2026
4Q
1Q
FY3/
2027
32
- Business Description and Performance
| KPI (Key Performance Indicators)
Core Systems Business
Medical
Nursing Care
YoY +1,643
facilities
Pharmacy
9,743
Target facilities
8,100
480
433
449
465
480
519
601
536
601
Approx.
2,385
2,385
2,228
2,102
502
1,707
1,707
584
2,228
2,177 2,216
2,234
2,337
2,277 2,291
250,000
facilities
2,234
2,234
Pharmacy
440
431
427
626
695
423
807
421
913
430
436
1,011 1,112
435
1,261
434
424
1,387 1,469
424
1,551
426
431
1,646 1,733
419
1,815
62,828 facilities
423
1,897
5,223 5,312
4,934 5,051 5,119
5,371 5,465 5,501
Medical Institutions
5,347
5,051
FY3/2023
FY3/2024
*2
113,585facilities
Our share
0.53.8
% %
Approx.
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q
FY3/2022
+
5,651
5,651
2,035
2,064 2,156
1,778 1,846 1,910 1,992
1,541 1,601 1,663 1,704
1,298 1,342 1,393 1,442 1,480
FY3/2021
*1
FY3/2025
Approx.
FY3/2026
+
Nursing Care Facility
*3
77,915 facilities
FY3/2027
*1. MHLW "Sanitary Administration Report (Mar 2023 preliminary)"
*2. MHLW "Medical Facilities Survey (Dec 2025 preliminary)"
*3. MHLW "Long - term Care Services Facilities Survey (Oct 2024)"
©kusurinomadoguchi, inc. All Right Reserved.
33
- Business Description and Performance
Core Systems Business
| Topics
Key Topics
Techno Network Co., Ltd.
Full Subsidiary Acquisition
In May 2026, we completed the full subsidiary acquisition of Techno Network Co.,
Ltd. with the objective of strengthening our business foundation in medical DX and
expanding our business scope.
About Techno Network
Techno
Network
is a certified
Medical Association's
Through this acquisition, in addition to our existing pharmacy services, we will
sales
further strengthen business development in EHR and medical information systems
system maintenance
for medical institutions.
a strong
As government - driven medical DX and EHR standardization progress, further
institutions,
market growth is anticipated. We will build a system capable of providing
integrated support from implementation through operation and maintenance.
standard
and implementation
provider
claims
support,
and operational
implementation
track
of ORCA
software),
and medical
(the Japan
offering
EHR
information
support . The company has
record
at numerous
medical
primarily in Kyushu .
Objective of Subsidiary Acquisition
Creating diverse synergy effects through integration with the
This initiative is a key step in our evolution into a medical IT company that expands
Group's existing customer base and services .
beyond the pharmacy sector into medical institutions, supporting DX advancement
⚫ New service creation
across the entire healthcare industry.
⚫ Operational efficiency improvement
⚫ Strengthening
the revenue base
⚫ Delivering added value to existing customers
©kusurinomadoguchi, inc. All Right Reserved.
etc .
34
- Business Description and Performance
Wellness Platform Business
©kusurinomadoguchi, inc. All Right Reserved.
- Business Description and Performance
Wellness Platform Business
*Wellness Platform Business has transferred medical check
| Business Model
- up services to Healthcare Automation Business as part of a business do
Kusurinomadoguchi
Health Screening
Support
Support for contracting and renewals with health
screening facilities, providing web - based booking systems
for insured members, encouraging non
- participants to get
screened, and consolidating invoices and health screening
results
Recurring Revenue
Non - recurring revenue
main restructuring.
We provide a web platform that allows participants to search
our affiliated pharmacies and choose consultation methods
including in - person, phone, or email. We also support the
entire process from participant identification to encouraging
non- participants to receive health screenings and completing
specific health guidance.
Specific Health
Guidance Service
KPI :Wellness Platform Business
Recurring Revenue
Non- recurring revenue
Recurring Revenue
(Millions of Yen)
Health checkup support users
14,059
(Millions of Yen)
47
Kusurinomadoguchi
Health Screening
Support
Health insurance
associations
Specific Health
Guidance Service
Fee per person for
initial consultation and
completion of specific
health guidance
Fee per person upon
completion of medical
checkup or health
screening
27
4
23
41
7
7
0
1Q
2Q
3Q
FY3/2026
©kusurinomadoguchi, inc. All Right Reserved.
10,928
6
23
Users
(cases)
15
4,971
3,573
12
13
1
10
4Q
1Q
FY3/2027
0
*1
1Q
2Q
3Q
4Q
FY3/2026
*1. Decrease due to seasonal nature of health check
- ups
*Starting this period, the revenue recognition policy has been revised to recognize revenue at the point of service
completion.
Recurring Revenue: Revenue expected on a continuing basis under monthly contracts.
Non - recurring revenue: One - time revenue such as initial setup fees.
1Q
FY3/2027
36
- Earnings Forecast for FY03/2027
©kusurinomadoguchi, inc. All Right Reserved.
- Earnings Forecast for FY03/2027
Earnings Forecast for FY03/2027
FY3/2022
FY3/2023
FY3/2024
FY3/2025
FY3/2026
FY3/2027
YoY
Revenue
6,489
7,420
8,721
11,199
12,330
14,400
Cost of goods sold
3,117
3,346
3,788
4,724
5,359
‐
‐
Gross Profit
3,372
4,074
4,932
6,475
6,970
‐
‐
SG&A expenses
2,657
3,024
3,562
4,521
4,288
‐
‐
Operating Profit
715
1,050
1,370
1,953
2,681
3,100
Ordinary Profit
815
938
1,325
1,940
2,666
3,100
Net Income Attributable to
Owners of Parent
515
391
870
2,034
2,952
3,100
Unit: million yen
©kusurinomadoguchi, inc. All Right Reserved.
38
Medium- Term Management Plan
©kusurinomadoguchi, inc. All Right Reserved.
- Medium- Term Management Plan
Management Resources & Competitive Advantages
Core Systems Business
Boosting productivity through advanced system implementation to
streamline operations.
We operate multiple businesses — Healthcare
Automation Business, Everyone's Medicine
Box Business, Core Systems Business, and
Wellness Platform Business
— generating
synergies across each and differentiating
ourselves from competitors.
Care Services(Care
records, billing
system)
Pharmacy
(Receipt computer
systems,Electronic
medication
records,Audit
system)
Furthermore, as part of our business expansion, we actively pursue
M&A (mergers and acquisitions) to meet customer needs, enter new
markets, and acquire new technologies.
Management
Consulting
In new businesses, we leverage our existing facility network and
Equipment
Accounting settlement, POS
systems, and membership/loyalty
program infrastructure
development
accumulated data to differentiate from competitors and deliver
unique value.
Hospital(Electronic
Medical Records,
Return Visit
Reception)
Inventory
Management
・Utilizing
proprietary data
Prescription
drug
procurement
・Comprehensive
Service Delivery
Mobilizing
inactive
inventory
business development.
Healthcare
Automation Business
Increase market awareness through
promotional activities to expand our
customer base.
©kusurinomadoguchi, inc. All Right Reserved.
Medication
Notebook
(Patient
Analysis)
Prioritizing cost reduction to achieve
efficient operations.
Business
Consulting
In this way, we pursue sustainable growth through diversified
Everyone’s Medicine
Box Business
Patient
Acquisition
(Booking)
System
Specific
health
guidance
Health
checkup
support
Wellness Platform
Business
Total healthcare support that
simultaneously improves checkup rates
and reduces operational burden.
40
- Medium- Term Management Plan
Expanding the Customer Base
We aim to reach 100,000 facilities by the end of FY3/2030.
Nursing Care Facility
Dispensing pharmacy
ARPU (thousand yen)
13.7
Medical Institutions
12.2
11.3
9.9
8.0
8.7
11.4
12.2
÷ Number of customers at quarter
ARPU = Average Recurring Revenue
13.7
14.0
13.8
14.5
14.1
12.9
13.3
14.0
14.7
22,265
500
470
458
626
807
15.3
15.2
facilities
10.3
8.8
53,441
38,795
25,018
13.8
14.6
55,253
6.6
23,578
14.6
26,261
567
913
27,293
28,012
28,400
28,577 29,359 30,084
592
681
799
854
1,011
1,112
1,261
1,387
953
1,469
30,642
31,631 32,528
33,497 35,307
3,520
3,272
1,160
1,274
1,551
1,646
1,362
1,733
1,386
1,815
41,317
42,458 43,268
1,683
1,897
2,793
3,777
4,021
44,393
4,277
2,234
45,624
46,982 47,625
11,025
12,477
5,065
5,446
2,277
2,291
2,337
2,385
4,616
2,234
2,216
2,228
39,888
40,079
40,391
37,019
37,882
39,640
36,465
38,774
35,620
1Q
2Q
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2,177
2,102
2,035
695
33,421
21,181
22,413
1Q
2Q
26,219
26,336
26,937
27,373
24,781
26,340
23,711
25,690
27,722
3Q
4Q
1Q
2Q
3Q
4Q
1Q
2Q
3Q
FY3/2021
FY3/2022
©kusurinomadoguchi, inc. All Right Reserved.
FY3/2023
28,536
29,327
29,917
30,479
4Q
1Q
2Q
3Q
FY3/2024
4Q
FY3/2025
FY3/2026
FY3/
2027
41
- Medium- Term Management Plan
Medium- term Management Plan
While steadily accumulating Recurring Revenue and securing stable profits,
we aim to achieve Recurring
Revenue of ¥20,000M and operating income of ¥5,000M or more by FY3/2030. We also set advancing to a
higher - tier market on the Tokyo Stock Exchange as a medium
- to- long - term goal.
Recurring Revenue
Non-recurring revenue
Projected Recurring Revenue
Operating Profit
Unit: million yen
Projected Non - recurring revenue
3,757
20,000
3,951
2,832
2,755
2,871
3,618
715
FY3/2022
4,665
5,889
1,050
1,050
1,370
1,370
FY3/2023
FY3/2024
©kusurinomadoguchi, inc. All Right Reserved.
7,247
1,954
1,954
FY3/2025
5,000
5,000
8,572
2,677
2,681
FY3/2026
3,100
3,100
FY3/2027
FY3/2030
42
Delivering new value to healthcare and contributing to
solving social issues through our business
We kindly ask for your support of the Kusurinomadoguchi Group.
©kusurinomadoguchi, inc. All Right Reserved.
43
Important Notes
Our consolidated financial statements are prepared in accordance
with Japanese accounting standards.
This material, including performance forecasts, is based on
information currently available to the Company and certain
assumptions deemed reasonable at this time. Actual results may
differ due to various risks and uncertainties, including changes in
economic conditions, customer needs, or legal regulations. We do not
guarantee the achievement of these forecasts.
IR Inquiries
E _mail
IR Site
Kusurinomadoguchi , Inc.
IR Manager, Corporate Administration
[email protected]
https://kusurinomadoguchi.co.jp/ir/
©kusurinomadoguchi, inc. All Right Reserved.
44